Pascale Richard

12.0k total citations · 1 hit paper
168 papers, 6.6k citations indexed

About

Pascale Richard is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Pascale Richard has authored 168 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Molecular Biology, 75 papers in Cardiology and Cardiovascular Medicine and 20 papers in Genetics. Recurrent topics in Pascale Richard's work include Cardiomyopathy and Myosin Studies (70 papers), Muscle Physiology and Disorders (39 papers) and Nuclear Structure and Function (37 papers). Pascale Richard is often cited by papers focused on Cardiomyopathy and Myosin Studies (70 papers), Muscle Physiology and Disorders (39 papers) and Nuclear Structure and Function (37 papers). Pascale Richard collaborates with scholars based in France, Italy and Germany. Pascale Richard's co-authors include Bernard Hainque, Ketty Schwartz, Gisèle Bonne, Philippe Charron, Lucie Carrier, Michel Komajda, Richard Isnard, Olivier Dubourg, Michel Desnos and Pascale Guicheney and has published in prestigious journals such as Nucleic Acids Research, Circulation and Nature Genetics.

In The Last Decade

Pascale Richard

159 papers receiving 6.5k citations

Hit Papers

Hypertrophic Cardiomyopathy 2003 2026 2010 2018 2003 250 500 750

Peers

Pascale Richard
Pascale Richard
Citations per year, relative to Pascale Richard Pascale Richard (= 1×) peers Ana Ferreiro

Countries citing papers authored by Pascale Richard

Since Specialization
Citations

This map shows the geographic impact of Pascale Richard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascale Richard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascale Richard more than expected).

Fields of papers citing papers by Pascale Richard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascale Richard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascale Richard. The network helps show where Pascale Richard may publish in the future.

Co-authorship network of co-authors of Pascale Richard

This figure shows the co-authorship network connecting the top 25 collaborators of Pascale Richard. A scholar is included among the top collaborators of Pascale Richard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascale Richard. Pascale Richard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ader, Flavie, Guillaume Jedraszak, Alexandre Janin, et al.. (2024). Prevalence and phenotypes associated with ALPK3 null variants in a large French multicentric cohort: Confirming its involvement in hypertrophic cardiomyopathy. Clinical Genetics. 105(6). 676–682. 4 indexed citations
2.
Vadrot, Nathalie, Flavie Ader, Maryline Moulin, et al.. (2023). Abnormal Cellular Phenotypes Induced by Three TMPO/LAP2 Variants Identified in Men with Cardiomyopathies. Cells. 12(2). 337–337. 4 indexed citations
3.
Perret, Claire, Carole Proust, Ulrike Esslinger, et al.. (2023). DNA ‐pools targeted‐sequencing as a robust cost‐effective method to detect rare variants: Application to dilated cardiomyopathy genetic diagnosis. Clinical Genetics. 105(2). 185–189. 1 indexed citations
4.
Perrin, Aurélien, Corinne Métay, Marcello Villanova, et al.. (2020). A new congenital multicore titinopathy associated with fast myosin heavy chain deficiency. Annals of Clinical and Translational Neurology. 7(5). 846–854. 9 indexed citations
5.
Ader, Flavie, Pascal de Groote, Patricia Réant, et al.. (2020). FLNC pathogenic variants in patients with cardiomyopathies: Prevalence and genotype-phenotype correlations. Archives of Cardiovascular Diseases Supplements. 12(1). 31–32. 7 indexed citations
6.
Ader, Flavie, Pascal de Groote, Patricia Réant, et al.. (2019). FLNC pathogenic variants in patients with cardiomyopathies: Prevalence and genotype‐phenotype correlations. Clinical Genetics. 96(4). 317–329. 57 indexed citations
7.
Baudry, Guillaume, Nicolas Mansencal, Pascale Richard, et al.. (2016). 0178 : Global and regional echocardiographic strain to assess early phase of hypertrophic cardiomyopathy due to sarcomeric mutations. Archives of Cardiovascular Diseases Supplements. 8(3). 241–241. 2 indexed citations
8.
Nelson, Isabelle, France Leturcq, Henri-Marc Bécane, et al.. (2015). Laminin α2 Deficiency-Related Muscular Dystrophy Mimicking Emery-Dreifuss and Collagen VI related Diseases. Journal of Neuromuscular Diseases. 2(3). 229–240. 26 indexed citations
9.
Richard, Pascale, Capucine Trollet, Teresa Gidaro, et al.. (2015). PABPN1 (GCN)11 as a Dominant Allele in Oculopharyngeal Muscular Dystrophy –Consequences in Clinical Diagnosis and Genetic Counselling. Journal of Neuromuscular Diseases. 2(2). 175–180. 15 indexed citations
10.
Eymard, B., Daniel Hantaı̈, Emmanuel Fournier, et al.. (2014). Syndromes myasthéniques congénitaux — L’expérience française. Bulletin de l Académie Nationale de Médecine. 198(2). 257–271. 1 indexed citations
11.
Friedrich, Felix W., Gilles Dilanian, Denise Juhr, et al.. (2012). A Novel Genetic Variant in the Transcription Factor Islet-1 Exerts Gain of Function on Myocyte Enhancer Factor 2C Promoter Activity. European Journal of Heart Failure. 15(3). 267–276. 21 indexed citations
12.
Claeys, Kristl G., Peter F. M. van der Ven, Anthony Béhin, et al.. (2009). Differential involvement of sarcomeric proteins in myofibrillar myopathies: a morphological and immunohistochemical study. Acta Neuropathologica. 117(3). 293–307. 54 indexed citations
13.
Béhin, Anthony, T. Stojkovic, Kristl G. Claeys, et al.. (2008). Desminopathies : What can we learn from a long term follow-up?. Neuromuscular Disorders. 18. 765.
14.
Triki, Chahnez, Madeleine Morinière, Ahmed Rebaï, et al.. (2007). Severe MDC1A Congenital Muscular Dystrophy Due to a Splicing Mutation in the LAMA2 Gene Resulting in Exon Skipping and Significant Decrease of mRNA Level. Genetic Testing. 11(3). 199–207. 11 indexed citations
15.
Lubieniecki, Fabiana, Soledad Monges, Alberto Dubrovsky, et al.. (2007). G.P.5.01 Inflammatory or ‘congenital myopathy’ type findings in muscle biopsies of patients with LMNA mutations. Neuromuscular Disorders. 17(9-10). 797–797. 2 indexed citations
16.
Allamand, Valérie, Corine Gartioux, Emmanuelle Lacène, et al.. (2007). C.O.3 Endoplasmic reticulum retention of COL6 chains in Ullrich congenital muscular dystrophy. Neuromuscular Disorders. 17(9-10). 833–833. 1 indexed citations
17.
18.
Bonne, Gisèle, Rabah Ben Yaou, L. Demay, et al.. (2002). Clinical analysis of 32 patients carrying R453W LMNA mutation. UCL Discovery (University College London). 2 indexed citations
19.
Richard, Pascale, Richard Isnard, Lucie Carrier, et al.. (1999). Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.. PubMed. 36(7). 542–5. 60 indexed citations
20.
Constans, J., Pascale Richard, & M. Viau. (1978). Relationship between Hp<sup>1</sup><sup>s</sup> and Hp<sup>2</sup> Gene Frequencies among Human Populations. Human Heredity. 28(5). 328–334. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026